FIGN
Basic information
Region (hg38): 2:163593396-163736012
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FIGN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 33 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 3 | 0 |
Variants in FIGN
This is a list of pathogenic ClinVar variants found in the FIGN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-163609662-C-T | not specified | Uncertain significance (Nov 23, 2021) | ||
2-163609752-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
2-163609788-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
2-163609800-A-C | not specified | Uncertain significance (Mar 30, 2024) | ||
2-163609899-T-C | not specified | Uncertain significance (Sep 14, 2021) | ||
2-163609923-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
2-163610010-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
2-163610022-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
2-163610050-T-G | not specified | Uncertain significance (Feb 17, 2022) | ||
2-163610163-C-T | not specified | Uncertain significance (May 23, 2023) | ||
2-163610220-A-G | not specified | Uncertain significance (May 26, 2023) | ||
2-163610226-C-A | not specified | Uncertain significance (Nov 18, 2022) | ||
2-163610278-T-G | not specified | Uncertain significance (Sep 01, 2021) | ||
2-163610358-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
2-163610397-G-T | not specified | Uncertain significance (Aug 13, 2021) | ||
2-163610450-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
2-163610457-C-T | not specified | Uncertain significance (Feb 17, 2022) | ||
2-163610458-G-T | not specified | Uncertain significance (Apr 20, 2023) | ||
2-163610570-T-G | not specified | Uncertain significance (Jun 01, 2023) | ||
2-163610627-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
2-163610646-T-C | not specified | Uncertain significance (Dec 19, 2023) | ||
2-163610757-T-C | not specified | Uncertain significance (Mar 30, 2024) | ||
2-163610865-T-C | not specified | Uncertain significance (May 27, 2022) | ||
2-163610886-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
2-163610958-C-T | not specified | Uncertain significance (Dec 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FIGN | protein_coding | protein_coding | ENST00000333129 | 2 | 142617 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.989 | 0.0108 | 124702 | 0 | 3 | 124705 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.16 | 358 | 425 | 0.842 | 0.0000240 | 4919 |
Missense in Polyphen | 97 | 136.08 | 0.71283 | 1576 | ||
Synonymous | -2.33 | 209 | 170 | 1.23 | 0.0000108 | 1579 |
Loss of Function | 4.00 | 2 | 22.4 | 0.0891 | 0.00000116 | 288 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000935 | 0.0000935 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000887 | 0.00000884 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: ATP-dependent microtubule severing protein. Severs microtubules along their length and depolymerizes their ends, primarily the minus-end, that may lead to the suppression of microtubule growth from and attachment to centrosomes. Microtubule severing may promote rapid reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. Microtubule release from the mitotic spindle poles may allow depolymerization of the microtubule end proximal to the spindle pole, leading to poleward microtubule flux and poleward motion of chromosome. {ECO:0000269|PubMed:22672901}.;
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.0659
- rvis_EVS
- -1.02
- rvis_percentile_EVS
- 8
Haploinsufficiency Scores
- pHI
- 0.544
- hipred
- Y
- hipred_score
- 0.644
- ghis
- 0.587
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.167
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fign
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; immune system phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- cell cycle;regulation of double-strand break repair via homologous recombination;cytoplasmic microtubule organization;microtubule severing;cell division
- Cellular component
- nucleus;cytoplasm;microtubule organizing center;microtubule;nuclear matrix
- Molecular function
- ATP binding;protein C-terminus binding;microtubule-severing ATPase activity;ATPase activity